Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$573,768,008
-$156,001,745 QoQ
Shares Held
2,259,196
-24.3% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#87
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caisse de depot et placement du Quebec holds $3,472,564,051 across 11 Drug Manufacturers - General names. JNJ ranks #2 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
805,809 | $966,511,569 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,259,196 | $573,768,008 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,448,107 | $571,581,749 | |
| 4 | ABBV |
AbbVie Inc.
|
1,641,631 | $413,100,024 | |
| 5 | AZN |
Astrazeneca PLC
|
1,463,843 | $277,573,909 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,083,390 | $263,215,492 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,228,503 | $243,646,342 | |
| 8 | BIIB |
Biogen Inc.
|
510,194 | $110,232,515 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $573,768,008 | 2,259,196 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $729,769,753 | 2,985,476 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $573,380,015 | 2,770,621 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $656,870,746 | 3,542,610 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $499,912,562 | 3,272,750 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $597,214,218 | 3,601,147 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $424,689,790 | 2,936,591 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $533,043,214 | 3,289,172 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $371,079,339 | 2,538,857 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $470,981,143 | 2,977,313 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $433,150,519 | 2,763,497 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $357,631,592 | 2,296,190 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $422,851,461 | 2,554,685 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $392,621,510 | 2,533,042 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $466,415,354 | 2,640,336 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $599,231,434 | 3,668,165 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $703,976,968 | 3,965,844 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $691,869,410 | 3,903,794 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $700,155,124 | 4,092,799 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $701,132,062 | 4,341,375 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $700,229,841 | 4,250,515 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $649,524,183 | 3,952,079 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $750,246,512 | 4,767,102 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $753,593,488 | 5,061,751 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $722,499,422 | 5,137,591 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $775,537,569 | 5,914,265 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||